Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfil3
|
ENSMUSG00000056749.7 | nuclear factor, interleukin 3, regulated |
Tef
|
ENSMUSG00000022389.8 | thyrotroph embryonic factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_52979915_52980103 | Nfil3 | 1064 | 0.502770 | 0.97 | 1.2e-03 | Click! |
chr13_52981218_52981551 | Nfil3 | 311 | 0.888785 | -0.95 | 3.9e-03 | Click! |
chr13_52982581_52982882 | Nfil3 | 1658 | 0.351370 | -0.94 | 6.0e-03 | Click! |
chr13_52974802_52975207 | Nfil3 | 6069 | 0.186315 | -0.92 | 9.6e-03 | Click! |
chr13_52994311_52994783 | Nfil3 | 13474 | 0.164204 | -0.92 | 9.7e-03 | Click! |
chr15_81831538_81831696 | Tef | 10674 | 0.091535 | -1.00 | 1.4e-05 | Click! |
chr15_81801453_81801720 | Tef | 835 | 0.357057 | 0.93 | 6.6e-03 | Click! |
chr15_81810304_81810460 | Tef | 664 | 0.538521 | -0.93 | 8.1e-03 | Click! |
chr15_81822793_81822946 | Tef | 1926 | 0.188012 | -0.92 | 8.6e-03 | Click! |
chr15_81802480_81802876 | Tef | 29 | 0.522236 | -0.92 | 9.6e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_48429034_48429208 | 60.16 |
Gm24325 |
predicted gene, 24325 |
8352 |
0.1 |
chr2_19701468_19701642 | 58.49 |
Gm24670 |
predicted gene, 24670 |
10267 |
0.15 |
chr16_10555941_10556092 | 57.62 |
Clec16a |
C-type lectin domain family 16, member A |
10607 |
0.17 |
chr8_84761164_84761339 | 56.93 |
Nfix |
nuclear factor I/X |
12145 |
0.11 |
chr13_93719775_93719928 | 50.94 |
AW495222 |
expressed sequence AW495222 |
676 |
0.6 |
chr12_24679446_24679817 | 50.68 |
Cys1 |
cystin 1 |
316 |
0.86 |
chr17_46139458_46139771 | 47.08 |
Rsph9 |
radial spoke head 9 homolog (Chlamydomonas) |
2784 |
0.15 |
chr2_79290258_79290413 | 46.66 |
Itga4 |
integrin alpha 4 |
34388 |
0.15 |
chr6_85813280_85813431 | 43.72 |
Nat8f6 |
N-acetyltransferase 8 (GCN5-related) family member 6 |
3492 |
0.11 |
chr10_111318102_111318256 | 42.15 |
Gm40761 |
predicted gene, 40761 |
18945 |
0.17 |
chr2_70867342_70867501 | 42.11 |
Gm13632 |
predicted gene 13632 |
10408 |
0.19 |
chr4_83441141_83441292 | 41.80 |
Snapc3 |
small nuclear RNA activating complex, polypeptide 3 |
12590 |
0.15 |
chr3_83966032_83966183 | 41.36 |
Tmem131l |
transmembrane 131 like |
2121 |
0.41 |
chr7_140723570_140723813 | 40.30 |
Olfr542-ps1 |
olfactory receptor 542, pseudogene 1 |
2409 |
0.15 |
chr15_41685709_41685874 | 39.86 |
Oxr1 |
oxidation resistance 1 |
24813 |
0.25 |
chr11_76120798_76120967 | 39.68 |
Vps53 |
VPS53 GARP complex subunit |
17866 |
0.16 |
chr3_95865315_95865481 | 39.54 |
Mrps21 |
mitochondrial ribosomal protein S21 |
2091 |
0.14 |
chr4_82390701_82390891 | 38.88 |
n-R5s188 |
nuclear encoded rRNA 5S 188 |
48614 |
0.16 |
chr4_141959732_141959897 | 38.70 |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
5620 |
0.14 |
chr8_17783842_17784014 | 36.80 |
Csmd1 |
CUB and Sushi multiple domains 1 |
248342 |
0.02 |
chr6_134461351_134461502 | 36.64 |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
3582 |
0.23 |
chr6_51695749_51695900 | 35.94 |
Gm38811 |
predicted gene, 38811 |
15257 |
0.23 |
chr9_85551927_85552078 | 35.74 |
Gm48834 |
predicted gene, 48834 |
1763 |
0.42 |
chr3_136048131_136048315 | 35.57 |
Gm5281 |
predicted gene 5281 |
3465 |
0.25 |
chr2_34475311_34475471 | 34.79 |
Mapkap1 |
mitogen-activated protein kinase associated protein 1 |
31044 |
0.15 |
chr14_114864274_114864425 | 34.69 |
Gm49010 |
predicted gene, 49010 |
12161 |
0.18 |
chr8_40270513_40270891 | 34.06 |
Fgf20 |
fibroblast growth factor 20 |
16251 |
0.2 |
chr10_113290359_113290532 | 34.05 |
Gm47532 |
predicted gene, 47532 |
133739 |
0.05 |
chr14_113945963_113946128 | 33.74 |
Gm5209 |
predicted gene 5209 |
44018 |
0.21 |
chr8_36246171_36246329 | 33.37 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
3266 |
0.26 |
chr16_42911354_42911708 | 32.75 |
Gm19522 |
predicted gene, 19522 |
534 |
0.77 |
chr12_78269881_78270053 | 32.71 |
Gm48225 |
predicted gene, 48225 |
8674 |
0.17 |
chr1_162891903_162892071 | 32.56 |
Fmo2 |
flavin containing monooxygenase 2 |
5472 |
0.19 |
chr8_110621566_110621725 | 31.91 |
Vac14 |
Vac14 homolog (S. cerevisiae) |
3033 |
0.28 |
chr16_43169836_43170008 | 31.46 |
Gm15712 |
predicted gene 15712 |
14651 |
0.21 |
chr4_108782032_108782195 | 30.55 |
Zfyve9 |
zinc finger, FYVE domain containing 9 |
1315 |
0.38 |
chr5_38117047_38117323 | 30.13 |
Stx18 |
syntaxin 18 |
3724 |
0.2 |
chr8_80977396_80977584 | 29.86 |
Gm9725 |
predicted gene 9725 |
36086 |
0.12 |
chr14_29030075_29030239 | 29.27 |
Lrtm1 |
leucine-rich repeats and transmembrane domains 1 |
9285 |
0.2 |
chr2_14589644_14589815 | 29.18 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
13359 |
0.13 |
chr2_72206740_72207276 | 29.09 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
8209 |
0.18 |
chr15_37099032_37099183 | 28.73 |
Gm9509 |
predicted gene 9509 |
73297 |
0.08 |
chr2_167496630_167496810 | 28.56 |
Spata2 |
spermatogenesis associated 2 |
3833 |
0.16 |
chrX_156479377_156479543 | 28.39 |
Gm23404 |
predicted gene, 23404 |
23365 |
0.24 |
chr11_111297916_111298094 | 28.10 |
Gm11675 |
predicted gene 11675 |
21905 |
0.28 |
chr9_106238297_106238448 | 27.87 |
Alas1 |
aminolevulinic acid synthase 1 |
358 |
0.77 |
chr3_21407235_21407424 | 27.49 |
Gm29137 |
predicted gene 29137 |
138239 |
0.05 |
chr1_24116155_24116306 | 27.24 |
Gm26607 |
predicted gene, 26607 |
9045 |
0.17 |
chr16_25221904_25222082 | 27.19 |
Tprg |
transformation related protein 63 regulated |
64824 |
0.14 |
chr7_119489931_119490282 | 26.76 |
Gm37518 |
predicted gene, 37518 |
8571 |
0.11 |
chr10_124590350_124590536 | 26.59 |
4930503E24Rik |
RIKEN cDNA 4930503E24 gene |
67005 |
0.14 |
chr13_16575272_16575646 | 26.40 |
Gm48497 |
predicted gene, 48497 |
41638 |
0.17 |
chr5_77315054_77315217 | 26.05 |
Gm42758 |
predicted gene 42758 |
3520 |
0.16 |
chr11_55158491_55158642 | 25.99 |
Slc36a3 |
solute carrier family 36 (proton/amino acid symporter), member 3 |
6858 |
0.12 |
chr8_48866088_48866239 | 25.95 |
Gm19744 |
predicted gene, 19744 |
10746 |
0.23 |
chr12_7751611_7751762 | 25.92 |
Gm32828 |
predicted gene, 32828 |
108005 |
0.06 |
chr2_129865084_129865235 | 25.62 |
Stk35 |
serine/threonine kinase 35 |
64642 |
0.1 |
chr8_36251596_36251950 | 25.56 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
2257 |
0.32 |
chr14_122602440_122602764 | 25.49 |
Pcca |
propionyl-Coenzyme A carboxylase, alpha polypeptide |
317 |
0.89 |
chr4_109785016_109785167 | 25.32 |
Gm12808 |
predicted gene 12808 |
30274 |
0.18 |
chr11_93907971_93908144 | 25.31 |
Mbtd1 |
mbt domain containing 1 |
1930 |
0.31 |
chr10_102127940_102128091 | 25.27 |
Mgat4c |
MGAT4 family, member C |
30843 |
0.24 |
chr7_98620703_98620867 | 25.23 |
Emsy |
EMSY, BRCA2-interacting transcriptional repressor |
5247 |
0.19 |
chr2_178555160_178555311 | 25.18 |
Cdh26 |
cadherin-like 26 |
94605 |
0.08 |
chr14_21033733_21033911 | 25.13 |
Vcl |
vinculin |
11819 |
0.18 |
chr19_29520625_29520778 | 24.92 |
A930007I19Rik |
RIKEN cDNA A930007I19 gene |
269 |
0.89 |
chrX_57836208_57836359 | 24.81 |
Gm14631 |
predicted gene 14631 |
82415 |
0.08 |
chr4_117948595_117948940 | 24.44 |
Artn |
artemin |
19004 |
0.11 |
chr16_43169614_43169782 | 24.11 |
Gm15712 |
predicted gene 15712 |
14875 |
0.21 |
chr8_36378677_36378838 | 23.90 |
Gm5787 |
predicted gene 5787 |
5124 |
0.22 |
chr16_37902225_37902391 | 23.82 |
Gpr156 |
G protein-coupled receptor 156 |
14188 |
0.14 |
chr1_70918439_70918607 | 23.63 |
Gm16236 |
predicted gene 16236 |
121507 |
0.06 |
chr12_39791346_39791497 | 23.58 |
Gm18116 |
predicted gene, 18116 |
26235 |
0.21 |
chr2_73628966_73629117 | 23.56 |
Chn1 |
chimerin 1 |
3301 |
0.21 |
chr18_6529974_6530138 | 23.51 |
Epc1 |
enhancer of polycomb homolog 1 |
13948 |
0.16 |
chr18_33352208_33352379 | 23.48 |
Gm5503 |
predicted gene 5503 |
32662 |
0.21 |
chr12_79676313_79676475 | 23.30 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
248339 |
0.02 |
chrX_77601507_77601673 | 23.30 |
Gm23121 |
predicted gene, 23121 |
22103 |
0.2 |
chr10_19471906_19472057 | 23.19 |
Gm33104 |
predicted gene, 33104 |
14734 |
0.21 |
chr3_62340981_62341146 | 23.11 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
38 |
0.91 |
chr12_69768209_69768388 | 23.10 |
Mir681 |
microRNA 681 |
4354 |
0.15 |
chr3_41138122_41138276 | 23.07 |
Gm40038 |
predicted gene, 40038 |
34464 |
0.16 |
chr13_52979672_52979858 | 23.00 |
Nfil3 |
nuclear factor, interleukin 3, regulated |
1308 |
0.43 |
chr10_24396476_24396638 | 22.99 |
Gm15271 |
predicted gene 15271 |
50933 |
0.14 |
chr5_8164154_8164307 | 22.91 |
Gm21759 |
predicted gene, 21759 |
15406 |
0.17 |
chr1_92113054_92113272 | 22.86 |
Hdac4 |
histone deacetylase 4 |
168 |
0.97 |
chr2_58763199_58763384 | 22.86 |
Upp2 |
uridine phosphorylase 2 |
2034 |
0.34 |
chr6_136906482_136906715 | 22.56 |
Erp27 |
endoplasmic reticulum protein 27 |
15542 |
0.11 |
chr19_30162949_30163115 | 22.41 |
Rpl31-ps20 |
ribosomal protein L31, pseudogene 20 |
2412 |
0.29 |
chr8_64747754_64747924 | 22.39 |
Klhl2 |
kelch-like 2, Mayven |
7132 |
0.16 |
chr5_99533469_99533635 | 22.35 |
Gm16227 |
predicted gene 16227 |
22870 |
0.17 |
chr9_44079482_44079643 | 22.31 |
Usp2 |
ubiquitin specific peptidase 2 |
5377 |
0.08 |
chr12_79453000_79453184 | 22.11 |
Rad51b |
RAD51 paralog B |
125739 |
0.05 |
chr4_88981150_88981311 | 22.06 |
Gm49890 |
predicted gene, 49890 |
42709 |
0.08 |
chr12_69767338_69767491 | 21.92 |
Mir681 |
microRNA 681 |
3470 |
0.16 |
chr8_56222915_56223078 | 21.91 |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
71589 |
0.11 |
chr17_27621069_27621255 | 21.84 |
Nudt3 |
nudix (nucleotide diphosphate linked moiety X)-type motif 3 |
1231 |
0.25 |
chr6_108486352_108486977 | 21.84 |
Mir7661 |
microRNA 7661 |
3079 |
0.21 |
chr14_120386371_120386531 | 21.79 |
Gm26679 |
predicted gene, 26679 |
2534 |
0.32 |
chr6_24610468_24610637 | 21.68 |
Lmod2 |
leiomodin 2 (cardiac) |
12790 |
0.14 |
chr1_92048460_92048628 | 21.65 |
Gm37036 |
predicted gene, 37036 |
26447 |
0.18 |
chr1_63122080_63122257 | 21.49 |
Gm20342 |
predicted gene, 20342 |
5050 |
0.11 |
chr1_194977569_194977733 | 21.33 |
Gm16897 |
predicted gene, 16897 |
691 |
0.46 |
chr12_69367282_69367438 | 21.19 |
Gm18113 |
predicted gene, 18113 |
2663 |
0.14 |
chr13_8987518_8987686 | 21.13 |
Gtpbp4 |
GTP binding protein 4 |
1511 |
0.23 |
chr9_23581358_23581532 | 21.11 |
Gm3011 |
predicted gene 3011 |
195047 |
0.03 |
chr4_101350294_101350475 | 21.02 |
Mir101a |
microRNA 101a |
3357 |
0.13 |
chr12_99247667_99248261 | 21.01 |
Gm19898 |
predicted gene, 19898 |
2293 |
0.29 |
chr13_4077186_4077340 | 20.99 |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
991 |
0.44 |
chr2_113503558_113503726 | 20.98 |
Gm13964 |
predicted gene 13964 |
392 |
0.86 |
chr2_4546547_4546716 | 20.94 |
Frmd4a |
FERM domain containing 4A |
13123 |
0.2 |
chr4_33467139_33467300 | 20.84 |
Gm11935 |
predicted gene 11935 |
14330 |
0.21 |
chr3_63296372_63296537 | 20.28 |
Mme |
membrane metallo endopeptidase |
359 |
0.92 |
chr5_101857129_101857304 | 20.24 |
Wdfy3 |
WD repeat and FYVE domain containing 3 |
5703 |
0.18 |
chr10_111367147_111367312 | 20.21 |
Gm40761 |
predicted gene, 40761 |
30105 |
0.16 |
chr10_4606032_4606193 | 20.19 |
Esr1 |
estrogen receptor 1 (alpha) |
5481 |
0.24 |
chr1_50806470_50806812 | 20.16 |
Gm28321 |
predicted gene 28321 |
8734 |
0.28 |
chr1_116184618_116184769 | 20.13 |
Gm23393 |
predicted gene, 23393 |
209720 |
0.03 |
chr6_59446350_59446583 | 20.04 |
Gprin3 |
GPRIN family member 3 |
20172 |
0.28 |
chr19_53165481_53165657 | 19.99 |
Gm24724 |
predicted gene, 24724 |
5706 |
0.16 |
chr6_24609749_24609900 | 19.99 |
Lmod2 |
leiomodin 2 (cardiac) |
12062 |
0.14 |
chr19_16179580_16179731 | 19.88 |
E030024N20Rik |
RIKEN cDNA E030024N20 gene |
14850 |
0.2 |
chr16_24877530_24877720 | 19.88 |
Gm22672 |
predicted gene, 22672 |
6548 |
0.24 |
chr6_50091440_50091611 | 19.87 |
Mpp6 |
membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) |
18716 |
0.22 |
chr1_155596686_155596848 | 19.86 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
29519 |
0.19 |
chr4_48239123_48239286 | 19.83 |
Erp44 |
endoplasmic reticulum protein 44 |
5270 |
0.22 |
chr4_102850868_102851049 | 19.79 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
19606 |
0.23 |
chr3_81149765_81149938 | 19.77 |
Gm16000 |
predicted gene 16000 |
109414 |
0.06 |
chr14_64154379_64154546 | 19.77 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
38148 |
0.11 |
chr3_116159479_116159643 | 19.71 |
Gm26544 |
predicted gene, 26544 |
9082 |
0.14 |
chr3_136853089_136853240 | 19.66 |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
18471 |
0.2 |
chr16_59855689_59855840 | 19.65 |
Epha6 |
Eph receptor A6 |
149957 |
0.04 |
chr6_100858577_100858772 | 19.56 |
Ppp4r2 |
protein phosphatase 4, regulatory subunit 2 |
6097 |
0.23 |
chr3_127009818_127009969 | 19.52 |
Gm43750 |
predicted gene 43750 |
908 |
0.45 |
chr10_75873620_75873791 | 19.51 |
Gm47744 |
predicted gene, 47744 |
1726 |
0.19 |
chr1_153065706_153066077 | 19.43 |
Gm28960 |
predicted gene 28960 |
23616 |
0.16 |
chr2_58785851_58786309 | 19.35 |
Upp2 |
uridine phosphorylase 2 |
20755 |
0.19 |
chr1_88908948_88909111 | 19.33 |
Gm4753 |
predicted gene 4753 |
23290 |
0.18 |
chr2_104594636_104594787 | 19.20 |
Cstf3 |
cleavage stimulation factor, 3' pre-RNA, subunit 3 |
4093 |
0.15 |
chr6_108535016_108535188 | 19.20 |
Gm44040 |
predicted gene, 44040 |
9415 |
0.15 |
chr8_11061835_11062015 | 19.20 |
B830042I05Rik |
RIKEN cDNA B830042I05 gene |
9121 |
0.15 |
chr3_12608407_12608567 | 19.19 |
Gm2429 |
predicted gene 2429 |
22773 |
0.28 |
chr17_45924651_45924805 | 19.18 |
Gm49805 |
predicted gene, 49805 |
37131 |
0.12 |
chr19_9028510_9028667 | 19.15 |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
28928 |
0.09 |
chr11_103696519_103696670 | 19.14 |
Gosr2 |
golgi SNAP receptor complex member 2 |
1100 |
0.31 |
chr9_72478306_72478457 | 19.09 |
Tex9 |
testis expressed gene 9 |
222 |
0.87 |
chr18_86383968_86384119 | 19.06 |
Neto1 |
neuropilin (NRP) and tolloid (TLL)-like 1 |
10909 |
0.24 |
chr2_181461638_181461798 | 19.04 |
Zbtb46 |
zinc finger and BTB domain containing 46 |
2292 |
0.18 |
chr13_31340004_31340178 | 18.98 |
Gm11373 |
predicted gene 11373 |
9324 |
0.16 |
chr16_30755886_30756050 | 18.87 |
Gm49754 |
predicted gene, 49754 |
37287 |
0.15 |
chr4_35068508_35068727 | 18.81 |
Ifnk |
interferon kappa |
83439 |
0.07 |
chr13_19701023_19701174 | 18.80 |
Nme8 |
NME/NM23 family member 8 |
3304 |
0.23 |
chr2_73940118_73940281 | 18.75 |
Gm13668 |
predicted gene 13668 |
20470 |
0.18 |
chr8_41069551_41069759 | 18.63 |
Mtus1 |
mitochondrial tumor suppressor 1 |
13121 |
0.16 |
chr3_52623461_52623624 | 18.62 |
Gm10293 |
predicted pseudogene 10293 |
10707 |
0.24 |
chr7_128507149_128507333 | 18.59 |
Gm40457 |
predicted gene, 40457 |
7054 |
0.12 |
chr2_113573929_113574081 | 18.56 |
Gm13964 |
predicted gene 13964 |
69971 |
0.1 |
chr15_75204876_75205037 | 18.55 |
Gm28117 |
predicted gene 28117 |
7289 |
0.12 |
chr6_72865397_72865562 | 18.55 |
Kcmf1 |
potassium channel modulatory factor 1 |
6585 |
0.19 |
chr8_104788622_104788782 | 18.48 |
Gm45782 |
predicted gene 45782 |
2874 |
0.14 |
chr18_8939705_8939905 | 18.40 |
Gm37148 |
predicted gene, 37148 |
11570 |
0.24 |
chr6_108327000_108327194 | 18.39 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
29157 |
0.22 |
chr8_54468376_54468527 | 18.37 |
Gm45553 |
predicted gene 45553 |
45699 |
0.14 |
chr1_105977505_105977686 | 18.37 |
Gm7160 |
predicted gene 7160 |
12657 |
0.14 |
chr12_103805644_103805795 | 18.37 |
Gm17043 |
predicted gene 17043 |
1357 |
0.28 |
chr7_44287784_44287958 | 18.34 |
Gm18307 |
predicted gene, 18307 |
5473 |
0.06 |
chr17_35808048_35808407 | 18.34 |
Ier3 |
immediate early response 3 |
13457 |
0.07 |
chr4_47366562_47366857 | 18.32 |
Tgfbr1 |
transforming growth factor, beta receptor I |
13099 |
0.22 |
chr4_129332605_129332774 | 18.29 |
Rbbp4 |
retinoblastoma binding protein 4, chromatin remodeling factor |
1955 |
0.21 |
chr11_16589661_16589834 | 18.23 |
Gm12663 |
predicted gene 12663 |
46319 |
0.12 |
chr17_70753482_70753646 | 18.22 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
2018 |
0.31 |
chr14_116350280_116350464 | 18.17 |
Gm38045 |
predicted gene, 38045 |
399843 |
0.01 |
chr1_84883028_84883184 | 18.16 |
Fbxo36 |
F-box protein 36 |
13955 |
0.15 |
chr9_30820894_30821215 | 18.15 |
Gm31013 |
predicted gene, 31013 |
39575 |
0.16 |
chr4_10854377_10854556 | 18.09 |
Gm12919 |
predicted gene 12919 |
623 |
0.61 |
chr12_104082595_104082890 | 18.08 |
Serpina4-ps1 |
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1 |
2093 |
0.18 |
chr6_88641424_88641714 | 17.93 |
Kbtbd12 |
kelch repeat and BTB (POZ) domain containing 12 |
3619 |
0.23 |
chrX_11997001_11997158 | 17.92 |
Gm14512 |
predicted gene 14512 |
12611 |
0.24 |
chr5_17296254_17296405 | 17.86 |
Gm6673 |
predicted gene 6673 |
68395 |
0.11 |
chr13_20205112_20205287 | 17.83 |
Elmo1 |
engulfment and cell motility 1 |
19992 |
0.25 |
chr5_149047906_149048073 | 17.83 |
Hmgb1 |
high mobility group box 1 |
2458 |
0.17 |
chr13_45863946_45864126 | 17.80 |
Atxn1 |
ataxin 1 |
8252 |
0.26 |
chr15_38292073_38292224 | 17.78 |
Klf10 |
Kruppel-like factor 10 |
6691 |
0.13 |
chr10_80344514_80344678 | 17.75 |
Adamtsl5 |
ADAMTS-like 5 |
642 |
0.42 |
chrX_103938627_103938778 | 17.73 |
Gm9166 |
predicted gene 9166 |
11718 |
0.16 |
chr8_93189262_93189430 | 17.70 |
Gm45909 |
predicted gene 45909 |
2012 |
0.24 |
chr6_52636243_52636417 | 17.66 |
Gm24355 |
predicted gene, 24355 |
3025 |
0.2 |
chr4_12015970_12016126 | 17.66 |
Gm11840 |
predicted gene 11840 |
7005 |
0.15 |
chr9_106236583_106237078 | 17.65 |
Alas1 |
aminolevulinic acid synthase 1 |
254 |
0.85 |
chr4_53039519_53039670 | 17.64 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
1332 |
0.41 |
chr12_103756020_103756184 | 17.64 |
Gm17042 |
predicted gene 17042 |
1369 |
0.28 |
chr19_26607966_26608130 | 17.59 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
778 |
0.65 |
chr2_141997354_141997555 | 17.57 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
158665 |
0.04 |
chr4_40184463_40184687 | 17.57 |
Aco1 |
aconitase 1 |
5955 |
0.19 |
chr1_172168265_172168469 | 17.56 |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
5587 |
0.11 |
chr6_85810645_85810799 | 17.50 |
Nat8f6 |
N-acetyltransferase 8 (GCN5-related) family member 6 |
859 |
0.39 |
chr5_151103422_151103608 | 17.43 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
5220 |
0.28 |
chr18_12524694_12525030 | 17.42 |
Gm29200 |
predicted gene 29200 |
20436 |
0.14 |
chr1_194314098_194314263 | 17.42 |
4930503O07Rik |
RIKEN cDNA 4930503O07 gene |
91421 |
0.09 |
chr15_22127008_22127164 | 17.34 |
Gm27525 |
predicted gene, 27525 |
146984 |
0.05 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 25.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
8.3 | 16.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
6.9 | 41.3 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
6.8 | 20.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
4.9 | 14.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
4.3 | 12.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.1 | 16.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
4.0 | 20.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
3.7 | 11.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.7 | 11.0 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
3.3 | 10.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.1 | 9.4 | GO:0006562 | proline catabolic process(GO:0006562) |
3.1 | 9.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
3.0 | 15.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
2.9 | 8.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.9 | 8.7 | GO:0035973 | aggrephagy(GO:0035973) |
2.9 | 8.7 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.9 | 11.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.8 | 8.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.8 | 16.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
2.7 | 10.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.7 | 5.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.6 | 10.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.6 | 7.7 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.6 | 12.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.6 | 5.1 | GO:0006573 | valine metabolic process(GO:0006573) |
2.6 | 7.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.4 | 9.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
2.4 | 7.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.4 | 7.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.4 | 7.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.3 | 4.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.3 | 9.2 | GO:0003099 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
2.3 | 11.5 | GO:1901525 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
2.2 | 44.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.2 | 24.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
2.2 | 6.7 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.2 | 4.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.2 | 15.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
2.1 | 8.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
2.1 | 8.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
2.1 | 6.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.0 | 6.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
2.0 | 10.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.0 | 4.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
2.0 | 5.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.9 | 9.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
1.9 | 9.7 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
1.9 | 9.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.9 | 3.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.9 | 5.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.9 | 9.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
1.9 | 5.7 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.9 | 7.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.9 | 3.7 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.8 | 10.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.8 | 8.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.8 | 1.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.8 | 5.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.8 | 5.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.8 | 1.8 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.8 | 5.3 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.8 | 5.3 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.7 | 5.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.7 | 13.6 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.7 | 5.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.7 | 5.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.6 | 8.2 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.6 | 4.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.6 | 9.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.6 | 14.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
1.6 | 4.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.6 | 4.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.6 | 3.2 | GO:0017145 | stem cell division(GO:0017145) |
1.6 | 11.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.6 | 10.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.5 | 4.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.5 | 6.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.5 | 7.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.5 | 4.4 | GO:0008050 | female courtship behavior(GO:0008050) |
1.5 | 4.4 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.5 | 13.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.5 | 5.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
1.5 | 2.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.5 | 1.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.5 | 8.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.5 | 8.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.5 | 10.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 5.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
1.4 | 10.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.4 | 10.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.4 | 4.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.4 | 5.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.4 | 6.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
1.4 | 4.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.3 | 8.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.3 | 4.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.3 | 4.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.3 | 9.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
1.3 | 2.7 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.3 | 5.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.3 | 6.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.3 | 5.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.3 | 5.2 | GO:0035627 | ceramide transport(GO:0035627) |
1.3 | 2.6 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.3 | 5.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
1.3 | 20.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.3 | 12.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.3 | 15.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.3 | 8.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.3 | 8.9 | GO:0060613 | fat pad development(GO:0060613) |
1.3 | 3.8 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.3 | 7.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.3 | 3.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.3 | 1.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.2 | 3.7 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.2 | 1.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 | 3.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.2 | 1.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
1.2 | 13.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 4.9 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.2 | 7.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.2 | 6.0 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.2 | 6.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.2 | 1.2 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
1.2 | 1.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.2 | 3.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 5.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.2 | 4.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.2 | 3.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.2 | 2.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.2 | 5.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.2 | 5.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.2 | 10.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.2 | 3.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.1 | 4.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 8.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 5.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.1 | 4.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.1 | 4.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 8.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.1 | 4.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.1 | 1.1 | GO:0032898 | neurotrophin production(GO:0032898) |
1.1 | 9.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.1 | 4.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 8.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.1 | 3.3 | GO:0030070 | insulin processing(GO:0030070) |
1.1 | 3.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 8.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
1.1 | 1.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.1 | 3.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.1 | 4.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.1 | 9.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.0 | 3.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.0 | 4.2 | GO:0007567 | parturition(GO:0007567) |
1.0 | 3.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.0 | 4.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.0 | 17.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
1.0 | 4.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.0 | 1.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
1.0 | 10.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.0 | 5.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.0 | 1.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
1.0 | 4.9 | GO:1904970 | brush border assembly(GO:1904970) |
1.0 | 3.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 3.0 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 1.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 2.9 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.0 | 1.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.0 | 3.9 | GO:0009597 | detection of virus(GO:0009597) |
1.0 | 1.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.0 | 6.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.0 | 2.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.0 | 2.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.0 | 2.9 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.9 | 7.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.9 | 3.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.9 | 0.9 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.9 | 0.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.9 | 9.3 | GO:0015816 | glycine transport(GO:0015816) |
0.9 | 0.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.9 | 2.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.9 | 6.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.9 | 10.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.9 | 3.7 | GO:0046618 | drug export(GO:0046618) |
0.9 | 1.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.9 | 0.9 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.9 | 1.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.9 | 0.9 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.9 | 4.5 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.9 | 1.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.9 | 4.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.9 | 4.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 2.7 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.9 | 1.8 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.9 | 10.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.9 | 2.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 1.8 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.9 | 7.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.9 | 1.8 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.9 | 1.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 21.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.9 | 6.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.9 | 6.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.9 | 1.7 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.9 | 3.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 2.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.9 | 4.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.8 | 10.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.8 | 3.4 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.8 | 4.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.8 | 2.5 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.8 | 6.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.8 | 2.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.8 | 1.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.8 | 18.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.8 | 9.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.8 | 3.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.8 | 0.8 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
0.8 | 1.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.8 | 22.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.8 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.8 | 3.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.8 | 2.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 3.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.8 | 5.6 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.8 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.8 | 2.4 | GO:0031296 | B cell costimulation(GO:0031296) |
0.8 | 1.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 1.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.8 | 3.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 3.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 4.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.8 | 4.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 2.3 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.8 | 1.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.8 | 4.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 3.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.8 | 1.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.8 | 5.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 1.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.8 | 13.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.8 | 25.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.8 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 3.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.8 | 6.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.8 | 5.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.7 | 9.0 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.7 | 4.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.7 | 11.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.7 | 2.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 5.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 2.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.7 | 5.8 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.7 | 3.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 8.6 | GO:0042026 | protein refolding(GO:0042026) |
0.7 | 1.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.7 | 7.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 2.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.7 | 2.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 2.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 8.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.7 | 9.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.7 | 0.7 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.7 | 2.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.7 | 1.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 4.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.7 | 0.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.7 | 3.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 1.4 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.7 | 2.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 0.7 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 4.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 2.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.7 | 5.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.7 | 2.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 3.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.7 | 1.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 2.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.7 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.7 | 15.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 9.4 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.7 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.7 | 2.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.7 | 2.0 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.7 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 2.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 2.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.7 | 3.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 16.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 1.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 7.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.7 | 2.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.7 | 2.0 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.6 | 2.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 3.9 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.6 | 3.9 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.6 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.6 | 1.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 2.6 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 0.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.6 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 3.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.6 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 59.0 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.6 | 1.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 2.6 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.6 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.6 | 12.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.6 | 3.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.6 | 4.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.6 | 4.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.6 | 1.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.6 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 18.1 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.6 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 4.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.6 | 3.7 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 4.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 9.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.6 | 0.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.6 | 2.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.6 | 4.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.6 | 0.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.6 | 1.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.6 | 5.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.6 | 1.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.6 | 1.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 5.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.6 | 2.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.6 | 1.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 5.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.6 | 2.9 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.6 | 12.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.6 | 1.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.6 | 9.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.6 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 11.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 2.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 2.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 0.6 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.6 | 2.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.6 | 5.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 15.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.6 | 0.6 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.6 | 1.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.6 | 7.8 | GO:0001967 | suckling behavior(GO:0001967) |
0.6 | 0.6 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.6 | 2.8 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 8.8 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 1.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 4.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 1.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 1.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.5 | 1.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.5 | 13.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 0.5 | GO:0048143 | astrocyte activation(GO:0048143) |
0.5 | 1.6 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 2.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.5 | 2.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 1.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 2.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.5 | 9.5 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.5 | 1.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 3.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 0.5 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.5 | 5.8 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.5 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 1.6 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.5 | 1.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 2.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 2.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.5 | 1.6 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 1.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 1.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.5 | 1.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.5 | 5.7 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.5 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 2.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.5 | 1.5 | GO:0046959 | habituation(GO:0046959) |
0.5 | 1.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.5 | 2.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.5 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.5 | 4.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 10.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.5 | 0.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.5 | 1.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 4.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 2.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 1.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.5 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 2.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 7.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 2.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 6.4 | GO:0042119 | neutrophil activation(GO:0042119) |
0.5 | 2.5 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.5 | 1.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.5 | 1.9 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.5 | 2.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 8.2 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.5 | 2.9 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.5 | 2.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 3.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 1.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 2.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.5 | 1.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 2.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.5 | 1.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 0.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.5 | 1.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.5 | 0.5 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.5 | 2.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 0.9 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.5 | 1.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.5 | 1.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 1.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 0.9 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.5 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 1.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.5 | 3.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.5 | 0.5 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.5 | 0.5 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.5 | 6.0 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.5 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 2.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 1.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 5.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 2.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 0.5 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.5 | 1.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 0.9 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.5 | 0.5 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.5 | 1.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 0.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 18.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 1.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.4 | 1.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.4 | 1.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 5.8 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.4 | 4.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 6.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 1.8 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 1.8 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.4 | 4.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.4 | 2.2 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.4 | 0.4 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.4 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.4 | 4.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.4 | 0.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.4 | 0.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.4 | 3.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 0.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 2.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.4 | 1.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 0.9 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 0.9 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.4 | 1.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 2.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.8 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 0.4 | GO:0015810 | aspartate transport(GO:0015810) |
0.4 | 6.7 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.4 | 2.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.4 | 2.1 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.4 | 0.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 0.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 4.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 0.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 3.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 9.4 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.4 | 0.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 2.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.4 | 1.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 3.6 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.8 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.4 | 0.8 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.4 | 1.2 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.4 | 0.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 2.0 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.4 | 2.8 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.4 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 2.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 1.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 1.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.4 | 2.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 0.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.4 | 1.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 2.4 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.4 | 19.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 0.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.4 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.4 | 8.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.4 | 0.8 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.4 | 12.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.4 | 6.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 0.8 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 1.6 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.4 | 1.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 1.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.4 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 0.8 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 1.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.4 | 2.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 3.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 9.2 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.4 | 4.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 0.4 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.4 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 8.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.4 | 3.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.4 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 0.8 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 2.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 2.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 7.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0048880 | sensory system development(GO:0048880) |
0.4 | 1.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.4 | 1.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 6.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 0.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.4 | 0.7 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.4 | 0.4 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.4 | 2.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 2.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 0.4 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.4 | 0.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.4 | 1.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.4 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 0.4 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.4 | 1.4 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 1.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 0.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 3.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 14.0 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.4 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 3.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 1.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 5.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.4 | 0.7 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.4 | 3.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 3.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.4 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 0.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 0.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 1.7 | GO:0030431 | sleep(GO:0030431) |
0.3 | 3.8 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.3 | 4.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 2.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 2.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 2.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.3 | 1.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.4 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.3 | 1.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 2.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.7 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.3 | 2.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 2.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 2.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 6.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.3 | 2.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 2.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 11.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 2.9 | GO:0070542 | response to fatty acid(GO:0070542) |
0.3 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 2.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 0.3 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.3 | 0.3 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.3 | 7.1 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.3 | 1.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 1.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.3 | 1.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 5.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 1.3 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.3 | 0.6 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.3 | 2.5 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.3 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.3 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 1.6 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.3 | 4.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.3 | 0.3 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.3 | 0.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 0.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.3 | 4.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.3 | 4.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.2 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 1.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 0.6 | GO:0036394 | amylase secretion(GO:0036394) |
0.3 | 2.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 3.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 1.8 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.3 | 0.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 9.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 0.3 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 0.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 2.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 0.6 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.3 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.6 | GO:2000553 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 1.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.3 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.3 | 9.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.3 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 2.3 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 1.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 13.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.3 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 0.9 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.3 | GO:0051503 | purine nucleotide transport(GO:0015865) adenine nucleotide transport(GO:0051503) |
0.3 | 0.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 2.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.3 | 8.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 8.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 5.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 3.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 3.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 0.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.3 | 0.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 0.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.3 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 4.4 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.3 | 1.9 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.3 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 1.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 0.8 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 5.0 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 0.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 0.5 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 0.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.3 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 0.8 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.3 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 1.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 0.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.3 | 7.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 6.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 5.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.5 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 0.3 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.3 | 0.3 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.3 | 1.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 0.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 2.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 1.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 1.1 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 5.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 0.5 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 2.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.3 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.5 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.8 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.3 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.5 | GO:0086067 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.3 | 2.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 1.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 0.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.8 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 3.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 0.3 | GO:0010458 | exit from mitosis(GO:0010458) |
0.3 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.3 | 1.5 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.3 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.3 | 0.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.3 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.3 | 2.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 1.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 2.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 23.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.2 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.2 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 1.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.2 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.2 | 1.9 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 4.5 | GO:0007588 | excretion(GO:0007588) |
0.2 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 1.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.2 | 0.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 1.6 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.2 | 0.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 1.6 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.7 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 1.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 1.4 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.2 | 2.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 0.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.2 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.7 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.9 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 3.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.2 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 2.9 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 0.2 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 3.8 | GO:0001825 | blastocyst formation(GO:0001825) |
0.2 | 1.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 4.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.2 | 0.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 2.0 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.2 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.2 | 0.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 5.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.7 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0002718 | regulation of cytokine production involved in immune response(GO:0002718) |
0.2 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.4 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.2 | 0.2 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.2 | 0.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.2 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 2.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 1.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 2.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.2 | 0.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 0.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.2 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.2 | 0.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 2.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 7.4 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.2 | 0.4 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 1.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.2 | 1.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.2 | 0.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.2 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.2 | 0.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.4 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 1.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 2.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 2.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 1.7 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 1.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.4 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 2.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 3.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 2.7 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 5.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 1.0 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 1.9 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 4.3 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.2 | 1.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.6 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 5.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.8 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.2 | 1.2 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 5.4 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.2 | 0.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 2.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 1.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.2 | 1.0 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 1.6 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 1.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 0.6 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 1.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.2 | 0.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 1.0 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 1.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 1.2 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.2 | 3.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 1.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.6 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.2 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.2 | 1.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 4.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.2 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.7 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 1.1 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.9 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.2 | 0.7 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.2 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 10.6 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.2 | 0.7 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.2 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 18.8 | GO:0034504 | protein localization to nucleus(GO:0034504) |
0.2 | 3.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.2 | 0.4 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.2 | 0.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.2 | 0.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 1.8 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 1.4 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 7.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.2 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 0.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.2 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.2 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.2 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 1.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.2 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.3 | GO:0032845 | negative regulation of homeostatic process(GO:0032845) |
0.2 | 1.0 | GO:0097202 | activation of cysteine-type endopeptidase activity(GO:0097202) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 0.3 | GO:0060147 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
0.2 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 1.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.2 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 1.4 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 1.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.2 | GO:0003072 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.2 | 0.8 | GO:0051875 | pigment granule localization(GO:0051875) |
0.2 | 1.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 1.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.2 | 0.7 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.3 | GO:0043200 | response to amino acid(GO:0043200) |
0.2 | 0.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 1.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.2 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 1.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.8 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.2 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.2 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 0.2 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 2.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.7 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.8 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.0 | GO:0003170 | heart valve development(GO:0003170) |
0.2 | 2.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 4.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 1.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 2.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 1.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 2.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.2 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 14.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.2 | 2.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.6 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.2 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 2.7 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.2 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 2.6 | GO:1903509 | liposaccharide metabolic process(GO:1903509) |
0.2 | 1.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.2 | 0.2 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.2 | 1.8 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
0.2 | 2.0 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.2 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.4 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.7 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 10.8 | GO:0048511 | rhythmic process(GO:0048511) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.1 | 4.0 | GO:0051216 | cartilage development(GO:0051216) |
0.1 | 2.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:1902579 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.1 | 0.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 12.1 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 3.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.1 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 6.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.9 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 1.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.1 | 1.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.8 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.4 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.3 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 3.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.8 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
0.1 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 2.8 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 1.4 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 1.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 1.2 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 2.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.3 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 6.3 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.6 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.4 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.1 | 0.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 2.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 1.1 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.4 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.1 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.8 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.4 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 1.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 8.8 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 1.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 1.4 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 1.7 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.1 | 0.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 1.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.0 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.1 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.8 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 4.5 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.1 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 2.3 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 3.6 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 1.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 10.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 1.7 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.4 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 3.4 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.9 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 1.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.6 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.2 | GO:0048644 | muscle organ morphogenesis(GO:0048644) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
0.1 | 0.6 | GO:0046888 | negative regulation of hormone secretion(GO:0046888) |
0.1 | 4.7 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.7 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 1.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.2 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.1 | 0.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.2 | GO:0098930 | axonal transport(GO:0098930) |
0.1 | 22.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.8 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.1 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.3 | GO:0044319 | wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.7 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.1 | GO:0048806 | genitalia development(GO:0048806) |
0.1 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 5.8 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.1 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 1.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.9 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 4.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.7 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:1990182 | exosomal secretion(GO:1990182) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.1 | GO:0060324 | face development(GO:0060324) |
0.1 | 1.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 2.0 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 1.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 1.1 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.7 | GO:0006023 | aminoglycan biosynthetic process(GO:0006023) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 1.7 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.1 | 0.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 1.1 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.4 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.3 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 2.5 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 0.6 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.6 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.3 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.6 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 3.7 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 2.3 | GO:0009749 | response to glucose(GO:0009749) |
0.1 | 0.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.3 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.7 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
0.1 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.8 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.1 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.7 | GO:0003279 | cardiac septum development(GO:0003279) |
0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.2 | GO:0052405 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) negative regulation by host of symbiont molecular function(GO:0052405) modulation by host of symbiont catalytic activity(GO:0052422) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.4 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 2.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.2 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.1 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.8 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.6 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.5 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 2.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.1 | 1.8 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:2000242 | negative regulation of reproductive process(GO:2000242) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 4.2 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.3 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.1 | GO:0003014 | renal system process(GO:0003014) |
0.1 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.6 | GO:0061326 | renal tubule development(GO:0061326) |
0.1 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.1 | 0.2 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.5 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
0.1 | 0.1 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 1.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.3 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.7 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.1 | 0.2 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.5 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.1 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 1.6 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.1 | 1.0 | GO:0016331 | morphogenesis of embryonic epithelium(GO:0016331) |
0.1 | 0.5 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 6.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0070169 | positive regulation of biomineral tissue development(GO:0070169) |
0.1 | 0.1 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 1.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0051170 | nuclear import(GO:0051170) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.2 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 0.3 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 1.0 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.1 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.1 | 0.1 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.9 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.1 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.2 | GO:1901292 | nucleoside phosphate catabolic process(GO:1901292) |
0.1 | 0.5 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 1.2 | GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity(GO:0051090) |
0.1 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 1.1 | GO:0051924 | regulation of calcium ion transport(GO:0051924) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 1.0 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 1.7 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 1.4 | GO:0050890 | cognition(GO:0050890) |
0.1 | 0.1 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.2 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.1 | 0.2 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.1 | 0.8 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.8 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.2 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.1 | 0.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.6 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.3 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 1.3 | GO:0048534 | hematopoietic or lymphoid organ development(GO:0048534) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.6 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:0045165 | cell fate commitment(GO:0045165) |
0.0 | 0.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.7 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.0 | 0.5 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.0 | 0.4 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.0 | 0.1 | GO:0060021 | palate development(GO:0060021) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.9 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.2 | GO:1901652 | response to peptide(GO:1901652) |
0.0 | 0.0 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.2 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 1.3 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.1 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.1 | GO:0009411 | response to UV(GO:0009411) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 41.7 | GO:0006351 | transcription, DNA-templated(GO:0006351) |
0.0 | 0.1 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 0.1 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.0 | 0.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.3 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.0 | 0.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.0 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 4.6 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.0 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.0 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.1 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 46.1 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0045927 | positive regulation of growth(GO:0045927) |
0.0 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.3 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.6 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0001822 | kidney development(GO:0001822) |
0.0 | 0.0 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.0 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.1 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.0 | 0.0 | GO:0019080 | viral gene expression(GO:0019080) |
0.0 | 0.0 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.5 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.0 | 0.2 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 1.0 | GO:0032259 | methylation(GO:0032259) |
0.0 | 1.1 | GO:0030036 | actin cytoskeleton organization(GO:0030036) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.0 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.5 | GO:0006865 | amino acid transport(GO:0006865) |
0.0 | 0.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.0 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.0 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.1 | GO:0002367 | cytokine production involved in immune response(GO:0002367) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:1904375 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.0 | 0.0 | GO:0071902 | positive regulation of protein serine/threonine kinase activity(GO:0071902) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.5 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.0 | 0.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.0 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.0 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0050795 | regulation of behavior(GO:0050795) |
0.0 | 0.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.0 | GO:1903650 | negative regulation of cytoplasmic transport(GO:1903650) |
0.0 | 0.0 | GO:0051303 | establishment of chromosome localization(GO:0051303) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.0 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 20.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
4.3 | 12.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.9 | 23.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.8 | 8.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.6 | 7.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
2.5 | 12.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.3 | 6.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 8.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.1 | 8.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.0 | 6.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.9 | 11.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.9 | 7.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.9 | 5.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.8 | 11.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.7 | 6.9 | GO:1990745 | EARP complex(GO:1990745) |
1.6 | 8.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.6 | 4.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.6 | 4.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.6 | 6.5 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 8.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.6 | 4.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.6 | 4.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.5 | 4.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.5 | 6.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.5 | 53.2 | GO:0031672 | A band(GO:0031672) |
1.4 | 6.9 | GO:0005579 | membrane attack complex(GO:0005579) |
1.3 | 12.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.3 | 10.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.3 | 7.8 | GO:0005915 | zonula adherens(GO:0005915) |
1.2 | 13.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.2 | 8.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.2 | 4.9 | GO:0070545 | PeBoW complex(GO:0070545) |
1.2 | 3.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.2 | 4.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.1 | 10.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.1 | 6.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.1 | 6.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.1 | 13.1 | GO:0005916 | fascia adherens(GO:0005916) |
1.0 | 6.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.0 | 12.1 | GO:0071564 | npBAF complex(GO:0071564) |
1.0 | 6.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.0 | 3.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 7.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.9 | 14.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.9 | 25.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.9 | 6.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.9 | 9.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.9 | 78.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.9 | 3.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.9 | 3.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 2.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.9 | 8.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 7.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.9 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.9 | 5.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.9 | 9.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.9 | 2.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.9 | 14.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.8 | 16.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.8 | 4.2 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 8.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.8 | 2.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 4.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 4.0 | GO:0097433 | dense body(GO:0097433) |
0.8 | 4.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 3.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 12.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.7 | 1.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 3.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.7 | 3.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.7 | 8.1 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 5.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.7 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 2.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.7 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 6.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 15.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 19.1 | GO:0015030 | Cajal body(GO:0015030) |
0.7 | 2.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 0.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.6 | 3.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 2.5 | GO:0044308 | axonal spine(GO:0044308) |
0.6 | 1.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 8.5 | GO:0001741 | XY body(GO:0001741) |
0.6 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 4.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.6 | 1.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.6 | 2.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 5.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.6 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
0.6 | 6.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 25.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 2.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 2.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 87.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 3.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 2.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.5 | 23.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 1.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 1.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 2.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.6 | GO:0030904 | retromer complex(GO:0030904) |
0.5 | 2.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 3.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 24.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 1.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 10.9 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 4.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 1.5 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 1.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 9.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.5 | 1.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 5.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 13.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 0.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 18.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 13.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.4 | 2.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 8.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 24.0 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 3.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 3.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 30.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.4 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 0.9 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 8.0 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.4 | 2.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 12.2 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 8.3 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.4 | 10.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 14.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.4 | 1.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 3.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 1.6 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 26.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 44.4 | GO:0005903 | brush border(GO:0005903) |
0.4 | 2.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 17.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 8.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 2.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.4 | 11.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 0.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.4 | 3.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 105.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 2.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 3.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 4.4 | GO:0038201 | TOR complex(GO:0038201) |
0.4 | 1.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 2.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.4 | 1.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.4 | 6.5 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 1.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 0.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 44.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 3.2 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.4 | 9.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.3 | 14.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 27.6 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 5.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 1.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 3.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 19.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 2.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 6.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 30.6 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 3.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.0 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.3 | 23.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 3.9 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 0.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 5.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.3 | 1.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 11.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 0.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.3 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 11.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 20.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 30.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 1.9 | GO:0000801 | central element(GO:0000801) |
0.3 | 1.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 1.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 3.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 9.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 40.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 4.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 3.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 5.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 1.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.1 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 5.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 4.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 4.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 4.0 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.3 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 11.9 | GO:0016605 | PML body(GO:0016605) |
0.3 | 1.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 3.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 7.2 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 2.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 8.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 4.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 16.4 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 6.0 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 1.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 2.6 | GO:0005901 | caveola(GO:0005901) |
0.2 | 21.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 9.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 8.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 177.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 4.2 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 238.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.2 | 6.0 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 5.3 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 1.4 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 22.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.7 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 2.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 3.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 8.4 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 1.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 6.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.3 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 4.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 1.5 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 25.4 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 2.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 152.9 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 29.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.2 | 12.4 | GO:0042995 | cell projection(GO:0042995) |
0.2 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 5.1 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 4.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 24.9 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 1.7 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 2.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.2 | 11.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 580.4 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 2.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.7 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 3.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 1.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 3.3 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 0.3 | GO:0005819 | spindle(GO:0005819) |
0.1 | 4.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 3.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 39.7 | GO:0005856 | cytoskeleton(GO:0005856) |
0.1 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 10.0 | GO:0030424 | axon(GO:0030424) |
0.1 | 1.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 48.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 71.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 170.6 | GO:0044424 | intracellular part(GO:0044424) |
0.1 | 1.9 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 6.3 | GO:0005622 | intracellular(GO:0005622) |
0.1 | 64.3 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 163.9 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 39.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
7.0 | 21.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
6.5 | 32.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
5.5 | 5.5 | GO:0009374 | biotin binding(GO:0009374) |
4.6 | 13.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
4.4 | 13.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.7 | 11.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.3 | 10.0 | GO:0008142 | oxysterol binding(GO:0008142) |
3.3 | 10.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.2 | 28.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.0 | 15.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
3.0 | 11.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.7 | 13.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.7 | 8.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
2.6 | 13.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.5 | 12.6 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
2.4 | 7.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.3 | 9.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.2 | 13.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.1 | 8.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.1 | 10.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
2.1 | 6.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.1 | 2.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.1 | 8.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.1 | 8.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.1 | 8.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
2.0 | 20.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.0 | 8.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.0 | 7.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.9 | 11.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
1.9 | 3.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.9 | 5.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.9 | 9.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.9 | 9.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.9 | 3.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.8 | 62.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
1.8 | 7.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.7 | 5.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.7 | 5.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.7 | 5.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.7 | 13.6 | GO:0034046 | poly(G) binding(GO:0034046) |
1.7 | 5.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.7 | 21.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.6 | 6.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.6 | 6.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.6 | 4.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.5 | 10.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.5 | 7.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.4 | 10.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.4 | 4.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 5.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.4 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.4 | 4.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
1.4 | 4.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.4 | 4.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.4 | 4.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.4 | 2.7 | GO:0043426 | MRF binding(GO:0043426) |
1.4 | 2.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.4 | 6.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 4.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.3 | 14.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.3 | 5.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.3 | 6.6 | GO:0042277 | peptide binding(GO:0042277) |
1.3 | 6.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.3 | 9.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.3 | 6.5 | GO:0070728 | leucine binding(GO:0070728) |
1.3 | 23.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.2 | 6.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.2 | 4.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.2 | 32.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.2 | 34.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
1.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.2 | 2.4 | GO:0032190 | acrosin binding(GO:0032190) |
1.2 | 3.5 | GO:0004802 | transketolase activity(GO:0004802) |
1.2 | 1.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.2 | 4.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 28.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.1 | 3.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.1 | 5.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 7.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 4.5 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.1 | 6.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.0 | 9.3 | GO:0048185 | activin binding(GO:0048185) |
1.0 | 4.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 4.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.0 | 3.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.0 | 14.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.0 | 3.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.0 | 2.0 | GO:0008143 | poly(A) binding(GO:0008143) |
1.0 | 26.4 | GO:0070888 | E-box binding(GO:0070888) |
1.0 | 10.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.0 | 2.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.0 | 3.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 3.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 2.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.9 | 8.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.9 | 69.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.9 | 5.5 | GO:0002054 | nucleobase binding(GO:0002054) |
0.9 | 2.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.9 | 7.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.9 | 2.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.9 | 3.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.9 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.9 | 1.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 6.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 3.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 0.9 | GO:0070905 | serine binding(GO:0070905) |
0.8 | 8.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.8 | 4.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 5.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.8 | 17.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.8 | 3.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 10.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 7.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.8 | 3.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.8 | 2.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.8 | 5.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.8 | 2.5 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.8 | 7.3 | GO:0031386 | protein tag(GO:0031386) |
0.8 | 1.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 1.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 2.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 6.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 9.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.8 | 6.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 2.3 | GO:0089720 | caspase binding(GO:0089720) |
0.8 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.8 | 2.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.8 | 3.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.8 | 2.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 17.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.8 | 14.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.8 | 9.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.7 | 9.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 0.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.7 | 18.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 2.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 8.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 1.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 10.1 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 2.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.7 | 14.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.7 | 12.2 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.7 | 7.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 2.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 4.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 2.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.7 | 13.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 2.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 2.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 3.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.7 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 2.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 2.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 4.7 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 15.4 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 6.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.7 | 0.7 | GO:0043398 | HLH domain binding(GO:0043398) |
0.7 | 3.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.7 | 8.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 19.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.6 | 1.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.6 | 2.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.6 | 3.2 | GO:0070737 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.6 | 5.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.6 | 30.0 | GO:0019209 | kinase activator activity(GO:0019209) |
0.6 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 8.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 9.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 2.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 10.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 5.5 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.6 | 16.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 1.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 5.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 2.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 0.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.6 | 2.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.6 | 12.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.6 | 4.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.6 | 4.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 1.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 18.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.6 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 19.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 9.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.6 | 1.7 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.6 | 2.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 1.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.6 | 3.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.6 | 0.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.6 | 7.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 3.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 2.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.6 | 9.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 1.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.6 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 0.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 0.5 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.5 | 23.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.5 | 7.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 17.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.5 | 4.9 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 9.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.5 | 1.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 2.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 3.1 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 1.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 5.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 2.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.5 | 2.6 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.5 | 49.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 2.0 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 3.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 6.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 6.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 1.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.5 | 2.0 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.5 | 1.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.5 | 1.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 3.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 1.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.5 | 1.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.5 | 11.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.5 | 11.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 1.4 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.5 | 1.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 43.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 2.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 1.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 1.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.5 | 8.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 15.2 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.5 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 4.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.5 | 9.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 2.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 3.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 10.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.8 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.3 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 2.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 2.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 3.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 5.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 4.0 | GO:0016208 | AMP binding(GO:0016208) |
0.4 | 0.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 28.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.4 | 1.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 9.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 4.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 0.9 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 32.1 | GO:0005496 | steroid binding(GO:0005496) |
0.4 | 18.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 6.8 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 3.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 9.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 1.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.3 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 5.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 14.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.4 | 83.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 0.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.4 | 6.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.4 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 6.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 4.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 5.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 2.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.4 | 3.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 4.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 9.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 6.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 1.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 1.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 1.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 1.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 49.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 5.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 7.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 3.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 8.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 16.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 0.7 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.4 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 3.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.4 | 2.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 1.8 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 2.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 5.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 5.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.3 | 0.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 1.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 3.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 11.5 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 1.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 4.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 0.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.3 | 1.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 3.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.0 | GO:0032564 | dATP binding(GO:0032564) |
0.3 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.3 | 6.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 2.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.3 | 1.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 1.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 1.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 11.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.3 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 19.9 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 2.5 | GO:0004672 | protein kinase activity(GO:0004672) |
0.3 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 1.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 6.8 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.3 | 2.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 3.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.3 | 11.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.3 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 11.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 1.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 3.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 4.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 2.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 2.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 0.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 3.5 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 9.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 3.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 5.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 5.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 2.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 10.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 3.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 4.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 2.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 3.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 1.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.3 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 3.6 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 1.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 6.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.3 | 8.8 | GO:0034892 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.3 | 0.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 0.8 | GO:0060229 | lipase activator activity(GO:0060229) |
0.3 | 12.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 4.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 9.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.3 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.3 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.3 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.3 | 5.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.3 | 2.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.3 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) peroxiredoxin activity(GO:0051920) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.5 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 15.1 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.2 | 8.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 3.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 2.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 2.4 | GO:0043747 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 2.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 4.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 2.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 3.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 4.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 5.5 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 40.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 2.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 4.1 | GO:0016597 | amino acid binding(GO:0016597) |
0.2 | 8.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 3.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 1.1 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 2.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.2 | 1.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.6 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.9 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 18.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.2 | 2.6 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 1.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 2.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 1.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 18.3 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 51.1 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.2 | 1.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 7.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 3.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 5.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 1.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 2.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 5.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.8 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 4.7 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 3.0 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 3.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 4.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 4.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 1.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.2 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.2 | 4.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 5.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 3.5 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 4.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 3.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 37.0 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 0.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 2.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 12.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 21.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 17.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 5.1 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 2.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.4 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.3 | GO:0034808 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.2 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 3.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 3.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 2.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 6.9 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.2 | 0.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.2 | 2.9 | GO:0046332 | SMAD binding(GO:0046332) |
0.2 | 0.6 | GO:0034912 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 4.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 5.4 | GO:0018724 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.2 | 1.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.5 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.2 | 4.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.2 | 9.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 71.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 39.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 1.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0018588 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 8.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 35.2 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 2.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 2.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 15.5 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.1 | 42.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 3.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 5.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.1 | 4.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 2.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 8.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 2.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 3.2 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.1 | 2.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 1.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 1.5 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.7 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 36.7 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 5.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 30.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 4.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 46.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:1901681 | sulfur compound binding(GO:1901681) |
0.1 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 10.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.2 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.1 | 1.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 7.3 | GO:0019901 | protein kinase binding(GO:0019901) |
0.1 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 5.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 3.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.2 | GO:0004871 | signal transducer activity(GO:0004871) |
0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 5.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 2.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.6 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 6.4 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 7.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 26.1 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 1.3 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.1 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.0 | 0.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) acetylcholine receptor inhibitor activity(GO:0030550) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.7 | GO:0030234 | enzyme regulator activity(GO:0030234) |
0.0 | 0.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 1.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 26.8 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.0 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 1.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 24.3 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 42.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
2.1 | 42.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 13.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.3 | 41.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.2 | 18.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.2 | 49.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.2 | 8.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.1 | 12.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 22.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.9 | 14.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 11.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 10.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 20.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 13.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 13.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 9.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.7 | 17.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.7 | 18.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 9.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 11.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.6 | 3.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 18.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 9.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 13.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 12.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 16.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 33.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 14.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 6.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 13.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 18.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 2.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 4.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 5.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 1.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 5.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 15.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 4.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 13.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 3.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 11.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 2.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 1.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 13.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 8.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 3.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 1.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 9.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 11.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 7.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 6.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 10.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 2.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 18.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.7 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 3.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 8.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.3 | PID ATM PATHWAY | ATM pathway |
0.3 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 1.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 5.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 5.1 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 5.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 2.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 3.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 3.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 5.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.0 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 3.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 5.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 5.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 3.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 5.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.8 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 1.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 1.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 3.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 22.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 4.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 17.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 13.7 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 4.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 39.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.6 | 26.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.5 | 32.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.1 | 36.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.6 | 4.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.6 | 6.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.6 | 20.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.5 | 11.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.4 | 14.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 24.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.4 | 25.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.4 | 16.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.3 | 14.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.3 | 4.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.2 | 10.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.2 | 49.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.1 | 18.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.1 | 23.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 14.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.0 | 25.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 9.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.0 | 16.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.0 | 1.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.0 | 10.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 14.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.0 | 4.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.9 | 9.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.9 | 24.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.9 | 6.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 12.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.8 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 3.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 14.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.8 | 30.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.8 | 7.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 11.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.7 | 1.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.7 | 5.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.7 | 9.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 4.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 18.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 0.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 8.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.6 | 8.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 1.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 23.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 6.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 9.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 4.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.6 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.6 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.6 | 7.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.5 | 8.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 5.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 3.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 52.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 10.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.5 | 5.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 17.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 18.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 3.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.5 | 6.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.5 | 5.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.5 | 8.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 4.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 10.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 2.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 4.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 17.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 4.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 5.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 8.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 1.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 5.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 4.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 9.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 13.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 7.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 11.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 7.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 2.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 7.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 18.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 4.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 5.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.4 | 6.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 2.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 6.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.4 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 5.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 6.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.4 | 3.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 6.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 6.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 5.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 7.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 2.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 14.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 4.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 1.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 7.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 3.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 3.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 5.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 5.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 4.6 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 16.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 4.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 12.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 1.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.3 | 0.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 3.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 3.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 2.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 3.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 2.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 11.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 2.1 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 6.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 2.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 3.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 3.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 11.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.2 | 14.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 11.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 3.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 14.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 3.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.2 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 5.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.7 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.2 | 1.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 6.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 6.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 2.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 1.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 28.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 4.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 3.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 10.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 2.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 5.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 3.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 12.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.9 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 2.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.5 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 4.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.0 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 3.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.2 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 4.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 12.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 2.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.1 | REACTOME ADAPTIVE IMMUNE SYSTEM | Genes involved in Adaptive Immune System |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.1 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.1 | 0.4 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 2.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.0 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |